Related Experiment Video
Updated: Jul 29, 2025
08:22
Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids
Published on: August 11, 2017
15.8K
3D Bioprinting for Vascularization
Amatullah Mir1, Eugenia Lee1, Wesley Shih1
1Section of Cardiac Surgery, Department of Surgery, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USA.
Bioengineering (Basel, Switzerland)
|May 27, 2023
Summary
This study explores 3D bioprinting for tissue constructs, focusing on optimizing vascularization strategies. Key factors include cell integration, bioink selection, and printing methods for successful clinical applications.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Tissue Engineering
Background:
- 3D-printed tissue constructs offer less invasive clinical treatment options.
- Successful development requires careful consideration of printing processes, materials, cells, and imaging.
- Current research faces challenges in achieving robust vascularization in 3D bioprinting models due to scalability and method variations.
Purpose of the Study:
- To analyze and evaluate various 3D bioprinting methods for successful vascularization.
- To identify optimal strategies for developing clinically applicable 3D bioprinted tissues with integrated vascular networks.
Main Methods:
- Review and analysis of different 3D printing techniques.
- Evaluation of various bioink materials and their physical properties.
- Assessment of cell types, including stem and endothelial cells, for bioprinting.
- Analysis of imaging techniques for construct evaluation.
Main Results:
- Identified key factors influencing successful vascularization in 3D bioprinting.
- Highlighted the importance of matching bioink properties to printing methods and desired tissue characteristics.
- Emphasized the role of specific cell combinations (stem and endothelial cells) in promoting vascular network formation.
Conclusions:
- Optimizing 3D bioprinting for vascularization requires a holistic approach considering printing technology, bioink, and cell choice.
- Strategic selection of these components is crucial for advancing the clinical translation of 3D bioprinted tissues.
